4D Pharma PLC (LBPS) Stock Earnings & Estimates
USA - NASDAQ:LBPS - US35085K1097 - ADR
1.65
+0.04 (+2.48%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 210K | 530K 152.38% | 520K -1.89% | 16.362M 3,046.54% | 17.01M 3.96% | 17.861M 5.00% | N/A | N/A | |
| EBITDA YoY % growth | -29.36M -5.20% | -29.34M 0.07% | -25.54M 12.95% | -24.24M 5.09% | -26.26M -8.33% | -28.381M -8.08% | -25.794M 9.11% | -23.678M 8.21% | |
| EBIT YoY % growth | -30.64M -5.22% | -30.54M 0.33% | -26.52M 13.16% | -17.17M 35.26% | -21.419M -24.75% | -26.986M -25.99% | N/A | N/A | |
| Operating Margin | -14,590.48% | -5,762.26% | -5,100.00% | -104.94% | -125.92% | -151.09% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A 29.90% | -1.18 -7.11% | -1.35 -14.89% | -1.54 -13.50% | -1.30 15.05% | -1.12 14.20% |
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2020 Q2Q % growth | -1.13 23.21% | % | ||
| Q2 2019 Q2Q % growth | -1.47 | -1.13 | -0.33 | -29.49% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in GBP, while estimates are .
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2021 Q2Q % growth | 290K 11.54% | % | ||
| Q2 2021 Q2Q % growth | 230K -17.86% | % | ||
| Q4 2020 Q2Q % growth | 260K 23.22% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |